Related Experiment Video
Updated: Feb 5, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Activation of viral defense signaling in cancer
Maria Gonzalez-Cao1, Niki Karachaliou2, Mariacarmela Santarpia3
1Rosell Oncology Institute (IOR), Dexeus University Hospital, Quironsalud Group, C/ Sabino Arana, 5, Barcelona 08028, Spain.
Abstract:
A coordinated action of innate and adaptive immune responses is required to efficiently combat a microbial infection. It has now become clear that cancer therapies also largely benefit when both arms of the immune response are engaged. In this review, we will briefly describe the current knowledge of innate immunity and how this can be utilized to prime tumors for a better response to immune checkpoint inhibitors. Comments on compounds in development and ongoing clinical trials will be provided.
Insights
Harnessing innate immunity can enhance cancer therapies. Engaging both innate and adaptive immune responses improves tumor treatment and response to immune checkpoint inhibitors.
Area of Science:
- Immunology
- Oncology
- Cancer Therapy
Background:
- Immune responses, both innate and adaptive, are crucial for fighting infections.
- Cancer therapies are increasingly leveraging the immune system for treatment.
- Engaging both innate and adaptive immunity is beneficial for effective cancer therapy.
Purpose of the Study:
- To review the role of innate immunity in cancer therapy.
- To explore how innate immunity can prime tumors for enhanced response to immune checkpoint inhibitors.
- To provide an overview of compounds in development and ongoing clinical trials.
Main Methods:
- Review of current knowledge on innate immunity.
- Analysis of strategies to utilize innate immunity in cancer treatment.
- Discussion of clinical trials and compounds in development.
Main Results:
- Innate immunity plays a critical role in initiating and shaping adaptive immune responses relevant to cancer.
- Priming tumors with innate immune stimuli can improve their susceptibility to immune checkpoint inhibitors.
- Several compounds and strategies targeting innate immunity are under investigation.
Conclusions:
- Coordinated innate and adaptive immune responses are essential for effective cancer immunotherapy.
- Targeting innate immunity offers a promising strategy to enhance the efficacy of immune checkpoint inhibitors.
- Further research and clinical trials are needed to fully realize the potential of innate immune-based cancer therapies.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Defenses Against Pathogens and Herbivores
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Viral Recombination
Viral Structure

